Applications Published 27 June 2001
Published: 8-Mar-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Local delivery of medications to the heart
Point Biomedical Corp 1109531*Oral micro-emulsion compsn of silybin
Hanmi Pharmaceuticals 1109532*Pulmonary delivery of liposome-encapsulated cannabinoids
Hung, Orlando; Her Majesty The Queen In Right Of Canada aa represented by the Minister of National Defence of Her Majesty's Canadian Government 1109533*Quick release pharmaceutical compsns of drug substances
Nycomed Danmark 1109534*Extended release acetaminophen
Ascent Pediatrics 1109535*New solid dose form of nanoparticulate naproxen
Elan Pharma 1109536*Immediate release tablet
AstraZeneca 1109537*Antiinflammatory pharmaceutical formulations
Norton Healthcare 1109538*Nanogel networks and biological agent compsn thereof
Supratek Pharma 1109539*Extended release acetaminophen
Ascent Pediatrics 1109540* Active ingredient support in the form of a film
LTS Lohmann Therapie-Systeme 1109541*Nitrosated and nitrosylated alpha-adrenergic receptor agonists, compsns and methods of use
Nitromed 1109542*Potassium channel inhibitors and method
Bristol-Myers Squibb 1109544*FC receptor modulators and uses thereof
Ilexus 1109545*Ophthlamic compsns for treating occular hypertension
Merck 1109546*New use of taxoid derivatives
Aventis Pharma 1109547*Compsns and methods for treating and preventing bone diseases using tocotrienols
Lipogenics 1109548*Analgesic use of podophyllotoxin for treating pain conditions in female genital organs
Saarela, Eero 1109549*Novel nitrophenylaziridien compounds and their use as prodrugs
Cancer Research Campaign Technology 1109550*Novel DNA-cleaving antitumour agents
Research Development Foundation 1109552*Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
Cornell Research Foundation 1109553*Pipecolic acid derivatives for vision and memory disorders
GPI NIL Holdings 1109554*Novel angiogenesis inhibitors
Merck & Co 1109555*New pharmaceutical uses for NOS inhibitors
Pfizer Products 1109556*A method for preventing the onset of asthma
UCB 1109557*Sustained release ranolazine formulations
CV Therapeutics 1109558*Inhibition of pathogenic processes related to tissue trauma
Hadasit Medical Research Services & Development 1109559*Compounds useful as AICARFT inhibitors
Agouron Pharmaceuticals 1109560*Promotors of neural regenration
The Regents of the University of California 1109561*Composite biocidal particles
Arch Chemicals 1109562*End modified thermal response hydrogels
Madash 1109563*Method of removal of HIV and other viruses from blood
Ambrus, Julian 1109564*Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
The University of Utah Research Foundation 1109565*An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor
Ludwig Institute for Cancer Research 1109568*Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
President and Fellows of Harvard College 1109569*Method of modulating memory effector T-cells and compsns
Biogen 1109570*Methods of treationg hypertension and compsns for use therein
Scios 1109571*Neuroprotection
Neuronz 1109572*Pharmaceutical compsns comprising factor XIIIA
Yeda Research & Development Company at the Weizman Institute of Science 1109573*Vaccines against sexually transmitted diseases
SmithKline Beecham Biologicals 1109574*Live virus vaccines to protect primates from HIV-1 infection and disease University of Kansas Medical
Centre 1109575*Immunogenic beta-propionamido-linked polysaccgaride protein conjugate useful as a vaccine produced using an N-acrylated polysaccharide
North American Vaccine 1109576*Multicomponent vaccines
Inhibitex 1109577*Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
Vanderbilt University 1109578*Use of TGF-beta inhibitors for treating cerebral disorders
Biopharm Gesellschaft zur Biotechnologischen Entwicklung und zum Vertrieb von Pharmaka 1109579*Methods for treating or preventing viral infections and associated diseases
Viropharm Inc 1109580*Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
Boston Scientific 1109583*GABA uptake inhibitors having a pyrrolidine structure
BDD Berolina Drug Development 1109783*Indolene derivatives as 5-HT2B and/or 5HT2C receptor ligands
Vernalis Research 1109784* Asta Medica 1109785*
Piperidine derivatives
F Hoffmann-La Roche 1109786*Arylpiperazines and their use as metalloproteinase inhibiting agents
AstraZeneca 1109787*Chemical process for preparing 2-hydroxy-6-trifluoromethylpyridine
Syngenta; Dow Agrosciences 1109788*Triptolide prodrugs having high aqueous solubility
Pharmagenesis 1109789*1,2,4-triazole-3-thione compounds
AstraZeneca 1109790*Aza-cyclodepsipeptides and their use as antiparasitics
Bayer 1109794*Thiazoline acid derivatives
University of Florida 1109795*Telomerase inhibitors and methods of their use
Geron; Kyowa Hakko Kogyo 1109796*Novel CDK inhibitors having flavone structure
LG Chemical 1109800*Substituted dihydrobenzopyrans useful as antiarrhythmic agents
Procter & Gamble 1109801*Spirofluoropyrans
Optische Werke 1109802*
